Meet our team in Phoenix.
The Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting takes place 4–8 November 2026 at the Phoenix Convention Center in Phoenix, Arizona. SITC remains the central global gathering for the cancer immunotherapy community—bringing together researchers, clinicians, and industry partners to examine the full arc of immuno-oncology, from early mechanistic science through to clinical translation and patient care.
Representing OCT Clinical at this year’s meeting will be Varvara Melnikova, Head of Business Development.
Our team has supported sponsors across a range of immunotherapy modalities and combination approaches, with a particular emphasis on trials conducted across European sites. If you are preparing an immuno-oncology study and want a direct, operational read on feasibility, patient access, or site startup in Europe, we are offering complimentary feasibility assessments during the SITC window.
To arrange a meeting in Phoenix, contact vmelnikova@octclinicalgroup.com. Whether your priority is early-phase design, European site strategy, study management, or registration planning, we are glad to sit down and talk through what would genuinely move your programme forward.
